More articles from Review

  • Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?
    Lauren Anne Buehler, MD, MPH, Dawn Noe, RDN, LD, CDCES, Shannon Knapp, BSN, RN, CDCES, Diana Isaacs, Pharm D, CDCES and Kevin M. Pantalone, DO, ECNU, FACE
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 547-555; DOI: https://doi.org/10.3949/ccjm.88a.20121

    A review of the potential risks and benefits for managing type 1 diabetes based on available evidence.

  • Coronary microvascular dysfunction: Considerations for diagnosis and treatment
    Coronary microvascular dysfunction: Considerations for diagnosis and treatment
    Benita Tjoe, MD, Lili Barsky, MD, Janet Wei, MD, Bruce Samuels, MD, Babak Azarbal, MD, C. Noel Bairey Merz, MD and Chrisandra Shufelt, MD, MS
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 561-571; DOI: https://doi.org/10.3949/ccjm.88a.20140

    A review of pathophysiology, considerations for invasive and noninvasive coronary function testing, management, and remaining knowledge gaps.

  • Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
    Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
    Milad Matta, MD, Serge C. Harb, MD, Paul Cremer, MD, Rory Hachamovitch, MD, MSc and Chadi Ayoub, MD, PhD, FACC, FASE, FSCCT
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 502-515; DOI: https://doi.org/10.3949/ccjm.88a.20068

    A review of current tests, what they measure, their diagnostic and prognostic value, and their limitations.

  • Medical, ethical, and legal aspects of end-of-life dilemmas in the intensive care unit
    Jonathan Wiesen, MD, Christopher Donatelli, MD, Martin L. Smith, STD, Laurel Hyle, JD, MPH and Eduardo Mireles-Cabodevila, MD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 516-527; DOI: https://doi.org/10.3949/ccjm.88a.14126

    Three hypothetical cases elucidate medical, ethical, and legal considerations in common end-of-life situations encountered in the ICU.

  • Antibody-mediated autoimmune encephalitis: A practical approach
    Justin R. Abbatemarco, MD, Chen Yan, MD, Amy Kunchok, MBBS and Alexander Rae-Grant, MD, FAAN, FRCPC
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 459-471; DOI: https://doi.org/10.3949/ccjm.88a.20122

    Symptoms may include subacute, progressive neuropsychiatric symptoms with associated cognitive dysfunction, movement disorders, and autoimmune seizures.

  • The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
    Asad Khan, MD, Erik H. Van Iterson, PhD and Luke J. Laffin, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 449-458; DOI: https://doi.org/10.3949/ccjm.88a.20098

    What should these patients be advised about weight management and about cardiorespiratory fitness, a major factor influencing the paradox?

  • The current state of tobacco cessation treatment
    Humberto K. Choi, MD, FCCP, Jorge Ataucuri-Vargas, MD, Charlie Lin, MD and Amanda Singrey, PharmD, BCACP, CTTS
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 393-404; DOI: https://doi.org/10.3949/ccjm.88a.20099

    Behavioral interventions and pharmacotherapy increase success rates. Alternative treatments should not replace or delay the use of known effective therapies.

  • Promoting physical activity in older women to maximize health
    Augustine Chavez, MD, Robert Scales, PhD and Juliana M. Kling, MD, MPH
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 405-415; DOI: https://doi.org/10.3949/ccjm.88a.20170

    The optimal type, intensity, and level required to achieve specific health outcomes depend on the disease the patient and clinician are trying to prevent or manage.

  • Medical complications of bulimia nervosa
    Allison Nitsch, MD, Heather Dlugosz, MD, Dennis Gibson, MD and Philip S. Mehler, MD, FACP, FAED
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 333-343; DOI: https://doi.org/10.3949/ccjm.88a.20168

    Complications can affect all body systems, but especially the renal and electrolyte systems.

  • Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
    Travis M. Howard, MD and Umesh N. Khot, MD
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 325-332; DOI: https://doi.org/10.3949/ccjm.88a.20113

    A review of current guidelines on the duration of therapy and perioperative management.

Pages